# Clofarabine Salvage Therapy in Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML)

> **NCT01295307** · PHASE2 · COMPLETED · sponsor: **Technische Universität Dresden** · enrollment: 86 (actual)

## Conditions studied

- Acute Myeloid Leukemia

## Interventions

- **DRUG:** Clofarabine

## Key facts

- **NCT ID:** NCT01295307
- **Lead sponsor:** Technische Universität Dresden
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-03
- **Primary completion:** 2013-09
- **Final completion:** 2013-12
- **Target enrollment:** 86 (ACTUAL)
- **Last updated:** 2015-10-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01295307

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01295307, "Clofarabine Salvage Therapy in Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML)". Retrieved via AI Analytics 2026-06-07 from https://api.ai-analytics.org/clinical/NCT01295307. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*